Set to release their quarterly reports after-market hours on Wednesday, March 18, Five Below FIVE and Micron Technology MU are two of the hottest stocks to consider at the moment. 

Providing quality

Shares of Frequency Electronics, Inc. FEIM have declined 11.4% since the company reported its earnings for the quarter ended Jan. 31, 2026, underperforming the S&P 500 index, which fell 2.1% over

Sometimes it helps to step back after results are out and let the market digest the numbers before concluding. Following its late-February earnings release, Nu Holdings NU saw its stock slide

Shares of Tredegar Corporation TG have underperformed the broader market following the release of its fourth-quarter results. The stock has declined 3.4% since the earnings announcement for the

There is always a bull market somewhere.

Despite shifting headlines and constantly evolving market narratives, certain stocks and sectors continue to benefit from prevailing economic regimes. In the

Reinsurance Group of America RGA is a leading global provider of traditional life and health reinsurance, as well as financial solutions, with operations across the United States, Latin America

Keros Therapeutics KROS enters 2026 with a clearer catalyst stack and a tighter operational focus. The near-term setup is led by rinvatercept, with study starts and regulatory interactions now

Keros Therapeutics KROS posted a dramatic revenue jump in 2025, but the mix matters as much as the magnitude. The shares also trade at a steep discount to book value, creating the classic biotech

Keros Therapeutics, Inc. KROS is pushing its lead asset, rinvatercept, into neuromuscular disease with Duchenne muscular dystrophy at the front of the line. The company is positioning the program